Division of Nephrology, University of Alabama at Birmingham, Birmingham, Alabama 35294, USA.
Clin J Am Soc Nephrol. 2013 May;8(5):804-9. doi: 10.2215/CJN.09240912. Epub 2013 Jan 31.
Arteriovenous thigh grafts are a potential vascular access option in hemodialysis patients who have exhausted all upper-limb sites. This study compared the outcomes of thigh grafts with outcomes obtained with dialysis catheters.
DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: A prospective vascular access database was queried to identify 209 thigh grafts placed from January 1, 2003, to June 30, 2011. The following were calculated: secondary graft survival (from graft creation to permanent failure), assisted primary graft survival (from graft creation to first thrombosis), and infection-free graft survival (from graft creation to first graft infection). Graft outcomes were compared with those observed with 472 tunneled internal jugular dialysis catheters.
The median duration of patient follow-up was 340 days for grafts and 91 days for catheters. The surgical technical failure rate of thigh grafts was 8.1% and was higher in patients with vascular disease (hazard ratio [HR], 2.94; 95% confidence interval [CI], 1.07-8.04; P=0.03). Secondary and assisted primary graft survival rates at 1, 2, and 5 years were 62%, 54%, and 38% and 38%, 27%, and 17%, respectively. Infection-free graft survival rates at 1, 2, and 5 years were 79%, 73%, and 61%. Secondary survival was much worse for dialysis catheters than thigh grafts (HR, 4.44; 95% CI, 3.65-5.22; P<0.001). Likewise, infection-free survival was far worse for catheters than for thigh grafts (HR, 3.77; 95% CI, 2.80-4.82; P<0.001).
Thigh grafts are a viable vascular option in patients who have exhausted upper-extremity options. Outcomes with thigh grafts are superior to those obtained with dialysis catheters.
在已经用尽所有上肢部位的血液透析患者中,动静脉大腿移植物是一种潜在的血管通路选择。本研究比较了大腿移植物的结果与透析导管的结果。
设计、设置、参与者和测量:通过前瞻性血管通路数据库,确定了 2003 年 1 月 1 日至 2011 年 6 月 30 日期间放置的 209 例大腿移植物。计算了以下内容:次级移植物存活率(从移植物创建到永久性失败)、辅助原发性移植物存活率(从移植物创建到第一次血栓形成)和无感染移植物存活率(从移植物创建到第一次移植物感染)。将移植物结果与 472 例隧道式颈内静脉透析导管的观察结果进行比较。
患者随访的中位时间为移植物 340 天和导管 91 天。大腿移植物的手术技术失败率为 8.1%,在患有血管疾病的患者中更高(风险比 [HR],2.94;95%置信区间 [CI],1.07-8.04;P=0.03)。1、2 和 5 年的次级和辅助原发性移植物存活率分别为 62%、54%和 38%和 38%、27%和 17%。1、2 和 5 年的无感染移植物存活率分别为 79%、73%和 61%。与大腿移植物相比,透析导管的次级存活率要差得多(HR,4.44;95%CI,3.65-5.22;P<0.001)。同样,与大腿移植物相比,无感染存活率对导管的影响要差得多(HR,3.77;95%CI,2.80-4.82;P<0.001)。
大腿移植物是已经用尽上肢部位的患者的可行血管选择。大腿移植物的结果优于透析导管的结果。